| scholarly article | Q13442814 |
| P2093 | author name string | Hee-Seung Bom | |
| Jung-Joon Min | |||
| Yeongjin Hong | |||
| Hyon E Choy | |||
| Hyung-Seok Kim | |||
| Vu H Nguyen | |||
| Taek-Keun Nam | |||
| Sheng-Nan Jiang | |||
| Thuy X Phan | |||
| P2860 | cites work | Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin | Q50102555 |
| Recombinant avirulent Salmonella vaccine strains with stable maintenance and high level expression of cloned genes in vivo | Q50196578 | ||
| Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. | Q50463859 | ||
| CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. | Q53259354 | ||
| Bacteria-mediated delivery of nanoparticles and cargo into cells | Q58620700 | ||
| Combination bacteriolytic therapy for the treatment of experimental tumors | Q24555050 | ||
| The complete genome sequence of Escherichia coli K-12 | Q27860542 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium | Q30491729 | ||
| Salmonella promoters preferentially activated inside tumors | Q33344346 | ||
| Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
| The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. | Q33800899 | ||
| Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer | Q33925546 | ||
| Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine | Q34120949 | ||
| Impact of tumor hypoxia and anemia on radiation therapy outcomes | Q34165838 | ||
| Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins | Q34301980 | ||
| Recent advances in the use of radiosensitizing nucleosides | Q34418287 | ||
| Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation | Q34418325 | ||
| Short hairpin RNA-expressing bacteria elicit RNA interference in mammals | Q34525784 | ||
| Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. | Q35149539 | ||
| Bacteria as tumour-targeting vectors | Q35215803 | ||
| Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
| Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth | Q35921725 | ||
| Inhibition of tumor growth using salmonella expressing Fas ligand | Q36812613 | ||
| Biological gene delivery vehicles: beyond viral vectors | Q37412239 | ||
| Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages | Q39538092 | ||
| Characterization of a pore-forming cytotoxin expressed by Salmonella enterica serovars typhi and paratyphi A. | Q39656445 | ||
| Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. | Q39837601 | ||
| Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth | Q39960374 | ||
| Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment | Q40022374 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Gene therapy for cancer: what have we done and where are we going? | Q40916302 | ||
| Molecular analysis of the cytolytic protein ClyA (SheA) from Escherichia coli | Q40945699 | ||
| Functional gene transfer from intracellular bacteria to mammalian cells | Q41484997 | ||
| IL-18-producing Salmonella inhibit tumor growth | Q42000711 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients | Q44591603 | ||
| Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium | Q45062759 | ||
| Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors | Q45882843 | ||
| Whole-body imaging of bacterial infection and antibiotic response | Q46929905 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo | Q47992263 | ||
| The lux genes of the luminous bacterial symbiont, Photobacterium leiognathi, of the ponyfish. Nucleotide sequence, difference in gene organization, and high expression in mutant Escherichia coli. | Q48207112 | ||
| P433 | issue | 3 | |
| P921 | main subject | Escherichia coli | Q25419 |
| adaptive radiation therapy | Q180507 | ||
| P304 | page(s) | 635-642 | |
| P577 | publication date | 2010-01-05 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy | |
| P478 | volume | 18 |
| Q34654013 | A novel balanced-lethal host-vector system based on glmS. |
| Q40937873 | Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy |
| Q33914020 | Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium |
| Q91890842 | Bacteria-cancer interactions: bacteria-based cancer therapy |
| Q50333648 | Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions |
| Q33870710 | Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors |
| Q92167324 | Bioengineered Escherichia coli Nissle 1917 for tumour-targeting therapy |
| Q39218115 | Construction of an inducible cell-communication system that amplifies Salmonella gene expression in tumor tissue |
| Q98466002 | Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting |
| Q50025874 | Effect of Salmonella treatment on an implanted tumor (CT26) in a mouse model |
| Q37605074 | Engineering Escherichia coli for light-activated cytolysis of mammalian cells. |
| Q34994526 | Engineering and visualization of bacteria for targeting infarcted myocardium |
| Q37316867 | Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent |
| Q37131536 | Engineering the perfect (bacterial) cancer therapy |
| Q41951958 | Functional motifs in Escherichia coli NC101. |
| Q50003353 | Identification of Staphylococcus aureus α-hemolysin as a protein drug that is secreted by anticancer bacteria and rapidly kills cancer cells |
| Q92063552 | Imaging of tumor colonization by Escherichia coli using 18F-FDS PET |
| Q28543432 | Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy |
| Q35053318 | In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis |
| Q37799436 | Infectious Causes of Colorectal Cancer |
| Q37115798 | Motility is critical for effective distribution and accumulation of bacteria in tumor tissue |
| Q30558192 | New paradigm for tumor theranostic methodology using bacteria-based microrobot |
| Q90136441 | Oncolytic Bacteria and their potential role in bacterium-mediated tumour therapy: a conceptual analysis |
| Q35579375 | Potent and tumor specific: arming bacteria with therapeutic proteins |
| Q91595611 | Programmable bacteria induce durable tumor regression and systemic antitumor immunity |
| Q46247736 | Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model. |
| Q57368286 | Radio frequency triggered curcumin delivery from thermo and pH responsive nanoparticles containing gold nanoparticles and its in vivo localization studies in an orthotopic breast tumor model |
| Q37418210 | Radiotherapy combined with an engineered Salmonella typhimurium inhibits tumor growth in a mouse model of colon cancer |
| Q64053631 | Redirecting Pore Assembly of Staphylococcal α-Hemolysin by Protein Engineering |
| Q50463465 | Rhodobacter sphaeroides, a novel tumor-targeting bacteria that emits natural near-infrared fluorescence. |
| Q36191597 | Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. |
| Q90618645 | Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy |
| Q39339432 | Salmonella-Mediated Cancer Therapy: Roles and Potential |
| Q64937659 | Switching between Magnetotactic and Aerotactic Displacement Controls to Enhance the Efficacy of MC-1 Magneto-Aerotactic Bacteria as Cancer-Fighting Nanorobots. |
| Q90608633 | Synthetic immunity by remote control |
| Q28069354 | Targeted Cancer Therapy Using Engineered Salmonella typhimurium |
| Q36184744 | Targeted deletion of the ara operon of Salmonella typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents |
| Q38670007 | The potential roles of bacteria to improve radiation treatment outcome. |
| Q64897634 | Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. |
| Q38812773 | Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy. |
| Q38130518 | Tumor-colonizing bacteria: a potential tumor targeting therapy |
| Q34427510 | Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review) |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q47587450 | Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin |
| Q56898750 | White paper on microbial anti-cancer therapy and prevention |
Search more.